Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control

Experimental Neurology

Volumn 247, Issue , 2013, Pages 73-79

  Liang, Yajie ^a   Ågren, Louise ^a   Lyczek, Agatha ^a   Walczak, Piotr ^a   Bulte, Jeff W M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BFGF; Bioluminescent imaging; Cell survival; Neural progenitor cells; Transplantation

Indexed keywords

DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 2; LENTIVIRUS VECTOR; LUCIFERASE; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; HELPER CELL; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSGENE; WILD TYPE;

BFGF; BIOLUMINESCENT IMAGING; CELL SURVIVAL; NEURAL PROGENITOR CELLS; TRANSPLANTATION;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; CELL COMMUNICATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; FIBROBLAST GROWTH FACTORS; FIREFLY LUCIFERIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEURAL STEM CELLS;

EID: 84876957328     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.04.001     Document Type: Article

References (41)

1. Agrawal A.K., Shukla S., Chaturvedi R.K., Seth K., Srivastava N., Ahmad A., Seth P.K. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol. Dis. 2004, 16:516-526.
2. Bacigaluppi M., Pluchino S., Martino G., Kilic E., Hermann D.M. Neural stem/precursor cells for the treatment of ischemic stroke. J. Neurol. Sci. 2008, 265:73-77.
3. Bakshi A., Shimizu S., Keck C.A., Cho S., LeBold D.G., Morales D., Arenas E., Snyder E.Y., Watson D.J., McIntosh T.K. Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur. J. Neurosci. 2006, 23:2119-2134.
4. Barker R.A., Dunnett S.B., Faissner A., Fawcett J.W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 1996, 141:79-93.
5. Baum C., Modlich U., Gohring G., Schlegelberger B. Concise review: managing genotoxicity in the therapeutic modification of stem cells. Stem Cells 2011, 29:1479-1484.
6. Berman S.C., Galpoththawela C., Gilad A.A., Bulte J.W., Walczak P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn. Reson. Med. 2011, 65:564-574.
7. Bradbury M.S., Panagiotakos G., Chan B.K., Tomishima M., Zanzonico P., Vider J., Ponomarev V., Studer L., Tabar V. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J. Neurochem. 2007, 102:2029-2039.
8. Cai C., Grabel L. Directing the differentiation of embryonic stem cells to neural stem cells. Dev. Dyn. 2007, 236:3255-3266.
9. Dayer A.G., Jenny B., Sauvain M.O., Potter G., Salmon P., Zgraggen E., Kanemitsu M., Gascon E., Sizonenko S., Trono D., Kiss J.Z. Expression of FGF-2 in neural progenitor cells enhances their potential for cellular brain repair in the rodent cortex. Brain 2007, 130:2962-2976.
10. Donato R., Miljan E.A., Hines S.J., Aouabdi S., Pollock K., Patel S., Edwards F.A., Sinden J.D. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci. 2007, 8:36.
11. Dorey K., Amaya E. FGF signalling: diverse roles during early vertebrate embryogenesis. Development 2010, 137:3731-3742.
12. Guo J.S., Zeng Y.S., Li H.B., Huang W.L., Liu R.Y., Li X.B., Ding Y., Wu L.Z., Cai D.Z. Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 2007, 45:15-24.
13. Hicks A.U., Lappalainen R.S., Narkilahti S., Suuronen R., Corbett D., Sivenius J., Hovatta O., Jolkkonen J. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur. J. Neurosci. 2009, 29:562-574.
14. Hockemeyer D., Soldner F., Cook E.G., Gao Q., Mitalipova M., Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 2008, 3:346-353.
15. Ito R., Takahashi T., Katano I., Ito M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9:208-214.
16. Jenny B., Kanemitsu M., Tsupykov O., Potter G., Salmon P., Zgraggen E., Gascon E., Skibo G., Dayer A.G., Kiss J.Z. Fibroblast growth factor-2 overexpression in transplanted neural progenitors promotes perivascular cluster formation with a neurogenic potential. Stem Cells 2009, 27:1309-1317.
17. Kallur T., Darsalia V., Lindvall O., Kokaia Z. Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J. Neurosci. Res. 2006, 84:1630-1644.
18. Kuhn H.G., Winkler J., Kempermann G., Thal L.J., Gage F.H. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. 1997, 17:5820-5829.
19. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
20. Liang Y., Walczak P., Bulte J.W. Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. J. Biomed. Opt. 2012, 17:016004.
21. Lu P., Jones L.L., Snyder E.Y., Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 2003, 181:115-129.
22. Marchionini D.M., Collier T.J., Camargo M., McGuire S., Pitzer M., Sortwell C.E. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J. Comp. Neurol. 2003, 464:172-179.
23. Maric D., Maric I., Chang Y.H., Barker J.L. Prospective cell sorting of embryonic rat neural stem cells and neuronal and glial progenitors reveals selective effects of basic fibroblast growth factor and epidermal growth factor on self-renewal and differentiation. J. Neurosci. 2003, 23:240-251.
24. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., Tamura A., Kirino T., Nakafuku M. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002, 110:429-441.
25. Niapour A., Karamali F., Nemati S., Taghipour Z., Mardani M., Nasr-Esfahani M.H., Baharvand H. Co-transplantation of human embryonic stem cell-derived neural progenitors and Schwann cells in a rat spinal cord contusion injury model elicits a distinct neurogenesis and functional recovery. Cell Transplant 2012, 21(5):827-843.
26. Niles L.P., Armstrong K.J., Rincon Castro L.M., Dao C.V., Sharma R., McMillan C.R., Doering L.C., Kirkham D.L. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci. 2004, 5:41.
27. Okada S., Ishii K., Yamane J., Iwanami A., Ikegami T., Katoh H., Iwamoto Y., Nakamura M., Miyoshi H., Okano H.J., Contag C.H., Toyama Y., Okano H. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 2005, 19:1839-1841.
28. Osakada F., Takahashi M. Neural induction and patterning in mammalian pluripotent stem cells. CNS Neurol. Disord. Drug Targets 2011, 10:419-432.
29. Park K.I., Himes B.T., Stieg P.E., Tessler A., Fischer I., Snyder E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp. Neurol. 2006, 199:179-190.
30. Politis M., Lindvall O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 2012, 10:1.
31. Pollock K., Stroemer P., Patel S., Stevanato L., Hope A., Miljan E., Dong Z., Hodges H., Price J., Sinden J.D. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurol. 2006, 199:143-155.
32. Rao M.S. Multipotent and restricted precursors in the central nervous system. Anat. Rec. 1999, 257:137-148.
33. Schumm M.A., Castellanos D.A., Frydel B.R., Sagen J. Improved neural progenitor cell survival when cografted with chromaffin cells in the rat striatum. Exp. Neurol. 2004, 185:133-142.
34. Sher F., van Dam G., Boddeke E., Copray S. Bioluminescence imaging of Olig2-neural stem cells reveals improved engraftment in a demyelination mouse model. Stem Cells 2009, 27:1582-1591.
35. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
36. Sortwell C.E., Pitzer M.R., Collier T.J. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp. Neurol. 2000, 165:268-277.
37. Stroemer P., Patel S., Hope A., Oliveira C., Pollock K., Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil. Neural Repair 2009, 23:895-909.
38. Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P., Svendsen C.N. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2007, 2:e689.
39. Wright J.A., Huang A. Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. Histol. Histopathol. 1996, 11:521-536.
40. Yan J., Welsh A.M., Bora S.H., Snyder E.Y., Koliatsos V.E. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J. Comp. Neurol. 2004, 480:101-114.
41. Zheng W., Nowakowski R.S., Vaccarino F.M. Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone. Dev. Neurosci. 2004, 26:181-196.